Analyzing Regional Healthcare Infrastructure and Its Influence on the Accessibility of Advanced Orphan Drug Therapies Globally
The accessibility of advanced treatments for Dravet syndrome varies significantly depending on the regional healthcare landscape. In North America and Western Europe, robust insurance systems and specialized pediatric epilepsy centers provide a high level of support for families, including access to the latest FDA and EMA-approved medications. However, in many other parts of the world, families...
0 Comments 0 Shares 634 Views